GlassScriptPhysician profile
Carl S Heller
NPI 1942225347
$1,513.50
in general payments reported to CMS, 2019-2025
28 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $247 · 2021: $227 · 2022: $191 · 2023: $95.22 · 2024: $177 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $365.41 | 2019-2023 | Shingrix |
| Abbvie INC. | $125.45 | 2021-2024 | |
| Astellas Pharma US INC | $113.41 | 2024-2025 | Veozah |
| Pfizer INC. | $99.46 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.05 | 2020 | |
| Abiomed | $72.97 | 2022-2025 | |
| Inspire Medical Systems, INC. | $68.85 | 2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $58.93 | 2024-2025 | Voquezna |
| Allergan, INC. | $54.92 | 2019-2020 | |
| Lucid Diagnostics INC. | $50.02 | 2022 | |
| Abbott Laboratories | $44.23 | 2022 | |
| Amgen INC. | $42.02 | 2019 | |
| Hologic Sales and Service, LLC | $37.02 | 2021 | |
| Globus Medical, INC. | $35.17 | 2025 | Senza |
| Dexcom, INC. | $33.43 | 2024 | Dexcom G6 Transmitter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $28.98 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $23.29 | 2023 | Quviviq |
| Si-Bone, INC. | $22.94 | 2021 | |
| Zimmer Biomet Holdings, INC. | $21.56 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Antares Pharma, INC. | $20.95 | 2024 | Xyosted |
| Boston Scientific Corporation | $19.92 | 2019 | |
| Exact Sciences Corporation | $17.43 | 2024 | Cologuard Collection Kit |
| Eisai INC. | $17.18 | 2020 | |
| Axsome Therapeutics, INC. | $15.07 | 2023 | Auvelity |
| Janssen Pharmaceuticals, INC | $13.36 | 2019 | |
| Amarin Pharma, INC. | $13.24 | 2019 | |
| Medtronic, INC. | $12.75 | 2021 | |
| Merck Sharp & Dohme LLC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.